QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

INVA

QT68Innoviva, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
22.49
-0.15-0.66%
OverviewShort InterestFilings
INVAQT68Innoviva, Inc.·NASDAQ
OverviewShort InterestFilings
22.49-0.66%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E3.33EPS (ttm)
6.01
Insider Own-
Shs Outstand73.81M
Perf Week0.22%
Market Cap1.67BForward P/E9.96EPS next Y2.26Insider Trans0.00%Shs Float-Perf Month3.50%
Enterprise Value1.40BPEG0.00EPS next Q0.44Inst Own-Short Float-Perf Quarter1.81%
Income501.98MP/S3.94EPS this Y-40.53%Inst Trans-Short Ratio-Perf Half Y12.90%
Sales424.13MP/B1.25EPS next Y-36.84%ROA27.46%Short Interest-Perf YTD12.51%
Book/sh18.18P/C9.14EPS next 5Y-12.55%ROE47.59%52W High25.15 -10.58%Perf Year4.90%
Cash/sh8.29P/FCF9.24EPS past 3/5Y-ROIC2.93%52W Low16.52 36.14%Perf 3Y-
Dividend Est.-EV/EBITDA2.19Sales past 3/5Y8.69% 4.75%Gross Margin76.20%Volatility1.78% 1.82%Perf 5Y-
Dividend TTM-EV/Sales3.30EPS Y/Y TTM1075.00%Oper. Margin14.85%ATR (14)0.63Perf 10Y-
Dividend Ex-DateSep 08, 2015Quick Ratio20.07Sales Y/Y TTM18.11%Profit Margin118.91%RSI (14)50.56Recom2.67
Dividend Gr. 3/5Y-Current Ratio21.13EPS Q/Q76.00%SMA201.03%Beta0.02Target Price37.00
Payout0.00%Debt/Eq0.25Sales Q/Q10.11%SMA50-1.38%Rel Volume1.86Prev Close22.64
Employees127LT Debt/Eq0.23EarningsAug 05SMA2006.82%Avg Volume755.07KPrice22.49
IPO DateOct 05, 2004Option/ShortYes / YesEPS/Sales Surpr.2.33% -3.92%Net Debt/EBITDA-0.42Volume1,403,827Change-0.66%
Analyst Ratings
DateActionAnalystRatingTarget
May-07-26ReiteratedBTIGBuy$35 → $42
Feb-26-26ReiteratedCantor FitzgeraldOverweight$32
Feb-17-26InitiatedBTIGBuy$35
Dec-16-25ReiteratedH.C. Wainwright$45 → $46
Sep-30-25InitiatedGoldman SachsSell$17
Aug-11-25InitiatedOppenheimer$35
Mar-07-25InitiatedScotiabankOutperform$55
Aug-08-22ReiteratedMorgan StanleyUnderweight$12 → $13
Jul-15-22ReiteratedMorgan StanleyUnderweight$12
Oct-31-16UpgradeCowen & Co.Market Perform → Outperform
Latest News
Jun-18-26
Jun-18-2611:40AM
Innoviva Inc (NASDAQ:INVA): A GARP Standout with 470% EPS Growth and a P/E of Just 6.05ChartMill
08:08AM
Nortiva Bio Launches Clinical-Stage Biopharmaceutical Company To Develop Long-Acting Oral MedicinesBenzinga
Jun-16-26
Jun-16-2608:05AM
Innoviva Specialty Therapeutics Inks Agreement With Dr. Reddy's Laboratories To Develop, Commercialize XACDURO To Treat Bacterial PneumoniaBenzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue424425359
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A10111837
Gross Profit324308322
Selling, General and Administrative Excl. Other117113116
Research and Development323114
Other Operating Expense111025
Operating Income63164167
Interest Expense171722
Unusual Expense
———
Non-Operating Income (Expense)-543-180107
Net Income Before Taxes60132737
Income Taxes965614
Consolidated Net Income50527123
Net Income From Continuing Operations50527123
Net Income50527123
EPS (Recurring)7.024.020.37
EPS (Basic, Before Extraordinaries)7.024.020.37
EPS (Diluted)6.013.300.36
EBITDA63938485
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio3.746.06—
Price To Sales Ratio3.933.15—
Gross Margin76.4272.4789.69
Operating Margin14.8638.5946.52
Net Margin119.1063.766.41
Shares Outstanding746763
Market Capitalization1,6641,339—
Operating Lease Expense
———
Insider Trading Volume
$26.21$23.37$20.52$17.67$14.83● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
DENNER ALEXANDER J10% OwnerMar 06 '25Sale17.521,196,74620,964,2375,658,705Mar 06 12:00 AM
DENNER ALEXANDER J10% OwnerMar 05 '25Sale17.63270,3744,766,1266,855,451Mar 06 12:00 AM
DENNER ALEXANDER J10% OwnerMar 04 '25Sale17.63151,1752,665,0797,125,825Mar 06 12:00 AM
Zhen MarianneChief Accounting OfficerNov 15 '23Sale13.9910,994153,81040,158Nov 17 12:00 AM
DENNER ALEXANDER J10% OwnerJun 15 '23Buy13.1362,000814,1967,277,000Jun 20 12:00 AM
DENNER ALEXANDER J10% OwnerJun 06 '23Buy13.058,000104,3847,215,000Jun 07 12:00 AM
DENNER ALEXANDER J10% OwnerJun 05 '23Buy13.047,00091,2977,207,000Jun 07 12:00 AM
DENNER ALEXANDER J10% OwnerMay 30 '23Buy13.01120,0001,560,6487,200,000May 30 12:00 AM
DENNER ALEXANDER J10% OwnerMay 26 '23Buy13.1230,000393,7297,080,000May 30 12:00 AM
DENNER ALEXANDER J10% OwnerMay 25 '23Buy13.0950,000654,3307,050,000May 30 12:00 AM
DENNER ALEXANDER J10% OwnerMay 19 '23Buy13.4836,000485,1477,000,000May 19 12:00 AM
DENNER ALEXANDER J10% OwnerMay 18 '23Buy13.0510,000130,5386,964,000May 19 12:00 AM
DENNER ALEXANDER J10% OwnerMay 17 '23Buy13.0750,000653,6906,954,000May 19 12:00 AM
DENNER ALEXANDER J10% OwnerMay 11 '23Buy12.34290,0003,577,4116,904,000May 15 12:00 AM
Raifeld PavelChief Executive OfficerMar 10 '23Buy10.873,00032,6039,799Mar 14 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR